| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF835-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-14079-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22235-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56708SS | |||
| Azide and BSA Free | NBP2-33244 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-93072-0.02ml | |||
![Immunohistochemistry-Paraffin: Granzyme M Antibody [NBP2-14079] - Staining in human lymph node and cerebral cortex tissues using anti-GZMM antibody. Corresponding GZMM RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/Granzyme-M-Antibody-Immunohistochemistry-Paraffin-NBP2-14079-img0005.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: Granzyme M Antibody [NBP2-14079] - Staining in human lymph node and cerebral cortex tissues using anti-GZMM antibody. Corresponding GZMM RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: Granzyme M Antibody [NBP2-14079] - Staining of human lymph node shows high expression.](http://images.novusbio.com/fullsize/Granzyme-M-Antibody-Immunohistochemistry-Paraffin-NBP2-14079-img0004.jpg)
![Immunohistochemistry-Paraffin: Granzyme M Antibody [NBP2-14079] - Staining of human cerebral cortex shows low expression as expected.](http://images.novusbio.com/fullsize/Granzyme-M-Antibody-Immunohistochemistry-Paraffin-NBP2-14079-img0003.jpg)
![Western Blot: Granzyme M Antibody (D1) [NBP3-41198] - Sample: Recombinant Granzyme M, Human.](http://images.novusbio.com/fullsize/nbp3-41198_mouse-granzyme-m-mab-d1-612202421373062.jpg "Western Blot: Granzyme M Antibody (D1) [NBP3-41198] - Sample: Recombinant Granzyme M, Human.")
![Immunohistochemistry-Paraffin: Granzyme M Antibody (D1) [NBP3-41198] - Vector Red staining on IHC-P; Samples: Human Tonsil Tissue; Primary Ab: 10ug/ml NBP3-41198; Second Ab: 2ug/mL HRP-Linked Caprine Anti-Mouse IgG Monoclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41198_mouse-granzyme-m-mab-d1-612202421273.jpg)
![Western Blot: Granzyme M Antibody - BSA Free [NBP3-46152] - Mouse lymph tissue were subjected to SDS PAGE followed by western blot with (Granzyme M antibody) at dilution of 1:500](http://images.novusbio.com/fullsize/nbp3-46152_rabbit-granzyme-m-pab-bsa-free-284202511511070.jpg "Western Blot: Granzyme M Antibody - BSA Free [NBP3-46152] - Mouse lymph tissue were subjected to SDS PAGE followed by western blot with (Granzyme M antibody) at dilution of 1:500")
![Western Blot: Granzyme M Antibody (4D11) [H00003004-M03] - detection against Immunogen (38.1 KDa) .](http://images.novusbio.com/fullsize/Granzyme-M-Antibody-4D11-Western-Blot-H00003004-M03-img0001.jpg "Western Blot: Granzyme M Antibody (4D11) [H00003004-M03] - detection against Immunogen (38.1 KDa) .")
![Western Blot: Chymotrypsin-like protease Antibody (10Z4K3) [NBP3-15845] - Western blot analysis of extracts of various cell lines, using Chymotrypsin-like protease Rabbit mAb (NBP3-15845) at 1:5000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.](http://images.novusbio.com/fullsize/Chymotrypsin-like-protease-Antibody-10Z4K3-Western-Blot-NBP3-15845-img0005.jpg "Western Blot: Chymotrypsin-like protease Antibody (10Z4K3) [NBP3-15845] - Western blot analysis of extracts of various cell lines, using Chymotrypsin-like protease Rabbit mAb (NBP3-15845) at 1:5000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.")
![Immunohistochemistry-Paraffin: Chymotrypsin-like protease Antibody (10Z4K3) [NBP3-15845] - Immunohistochemistry of paraffin-embedded mouse pancreas using Chymotrypsin-like protease Rabbit mAb (NBP3-15845) at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/Chymotrypsin-like-protease-Antibody-10Z4K3-Immunohistochemistry-Paraffin-NBP3-15845-img0002.jpg)
![Immunohistochemistry-Paraffin: Chymotrypsin-like protease Antibody (10Z4K3) [NBP3-15845] - Immunohistochemistry of paraffin-embedded rat pancreas using Chymotrypsin-like protease Rabbit mAb (NBP3-15845) at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/Chymotrypsin-like-protease-Antibody-10Z4K3-Immunohistochemistry-Paraffin-NBP3-15845-img0001.jpg)
![Immunocytochemistry/ Immunofluorescence: Chymotrypsin-like protease Antibody (10Z4K3) [Chymotrypsin-like protease] - Confocal imaging of paraffin-embedded Mouse pancreas tissue using Chymotrypsin-like protease Rabbit mAb followed by a further incubation with Cy3 Goat Anti-Rabbit IgG (H+L) . DAPI was used for nuclear staining (Blue). Objective: 40x. Perform high pressure antigen retrieval with 0.01 M citrate buffer (pH 6.0) prior to IF staining.](http://images.novusbio.com/fullsize/nbp3-15845_rabbit-chymotrypsin-like-protease-mab-10z4k3-5220251718910.jpg)
![Immunocytochemistry/ Immunofluorescence: Chymotrypsin-like protease Antibody (10Z4K3) [Chymotrypsin-like protease] - Confocal imaging of paraffin-embedded Rat pancreas tissue using Chymotrypsin-like protease Rabbit mAb followed by a further incubation with Cy3 Goat Anti-Rabbit IgG (H+L) . DAPI was used for nuclear staining (Blue). Objective: 40x. Perform high pressure antigen retrieval with 0.01 M citrate buffer (pH 6.0) prior to IF staining.](http://images.novusbio.com/fullsize/nbp3-15845_rabbit-chymotrypsin-like-protease-mab-10z4k3-52202517152720.jpg)
![Immunocytochemistry/ Immunofluorescence: Chymotrypsin-like protease Antibody (10Z4K3) [Chymotrypsin-like protease] - Confocal imaging of paraffin-embedded Human pancreas tissue using Chymotrypsin-like protease Rabbit mAb followed by a further incubation with Cy3 Goat Anti-Rabbit IgG (H+L) . DAPI was used for nuclear staining (Blue). Objective: 40x. Perform high pressure antigen retrieval with 0.01 M citrate buffer (pH 6.0) prior to IF staining.](http://images.novusbio.com/fullsize/nbp3-15845_rabbit-chymotrypsin-like-protease-mab-10z4k3-5220251718943.jpg)
![Western Blot: Chymotrypsin-like protease Antibody (SR1373) [NBP3-22235] - Western blot analysis using NBP3-22235 in Mouse pancreas lysate.](http://images.novusbio.com/fullsize/nbp3-22235_rabbit-chymotrypsin-like-protease-mab-sr1373-5720231716186.jpg "Western Blot: Chymotrypsin-like protease Antibody (SR1373) [NBP3-22235] - Western blot analysis using NBP3-22235 in Mouse pancreas lysate.")
![Western Blot: Mouse Monoclonal Caspase-3 Antibody (31A1067) - (Pro and Active) [IMGENEX: IMG-144A] [NB100-56708] - Whole cell lysates from MDA-MB-231, MCF-7, SUM149 and SUM159 cells were loaded with 50 ug/lane. 10% SDS-PAGE. Caspase-3 Antibody (NB100-56708) was used for primary antibody: 1:2000, 4℃, overnight. Image from a verified customer review.](http://images.novusbio.com/fullsize/antibody/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-imgenex-img-144a-western-blot-3112024145834..png)
![Immunocytochemistry/ Immunofluorescence: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - rOPN administration influenced the interaction & balance between Beclin 1 & Caspase‐3 at 24 h after SAH. Double immunofluorescence staining of Caspase‐3 & Beclin 1 in Sham group, SAH + Vehicle group & SAH + rOPN group at 24 h after SAH induction. Sample size is 9, n = 3 per group. Localization of Caspase‐3 can be cytoplasmic & nuclear. Staining in the nucleus is considered to be an indication of active Caspase‐3. The dashed lines & the red box on brain slice images indicate the locations observed. Vehicle, phosphate‐buffered saline; Scale bar = 50 μm Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31436915), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-310202415175231.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - PEM induces YIPF2 upregulation & apoptosis in NSCLC cells.a, b H1792 (a) & H1299 (b) NSCLC cells were treated with PEM at various concentrations (0–10.0 μM) for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2 & ACTB. c Overexpression of YIPF2 in H1299 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, CASP8, CASP3, PARP1 & ACTB. d Knockdown of YIPF2 expression by YIPF2–1 siRNA in A549 NSCLC cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, CASP8, CASP3, PARP1 & ACTB. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32303681), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-310202415175219.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - PEM induces YIPF2 upregulation & apoptosis in NSCLC cells.a, b H1792 (a) & H1299 (b) NSCLC cells were treated with PEM at various concentrations (0–10.0 μM) for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2 & ACTB. c Overexpression of YIPF2 in H1299 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, CASP8, CASP3, PARP1 & ACTB. d Knockdown of YIPF2 expression by YIPF2–1 siRNA in A549 NSCLC cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, CASP8, CASP3, PARP1 & ACTB. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32303681), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-310202415371987.jpg)
![Immunocytochemistry/ Immunofluorescence: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - Lipofection of top broccoletti-miR candidates does not influence basal & induced apoptosis.(A) BxPc-3 & Bx-Gem cells were transfected as described in Figure 3. Seventy-two hours later, the cells were stained with Annexin V-PE & 7-AAD, followed by FACS analysis. The percentage of Annexin V- & 7-AAD-positive cells is shown. (B) Lipofected BxPc-3 & Bx-Gem cells were stained with an antibody specific for the proliferation marker Ki-67 (green) or the apoptosis marker cleaved fragment of caspase-3 (red), which indicates apoptosis. Representative images at ×100 magnification are shown. The percentage of Ki-67- or caspase-3-positive cells was counted in 18 visual fields, & the means ± SD are shown in the diagram below. (C) BxPc-3 & Bx-Gem were lipofected as described above, & at 24 h later, the cells were treated with gemcitabine (10 nM) or were left untreated. Ninety-six hours after gemcitabine treatment, viability was determined by MTT assay. The data are presented as the means ± SD (**P < 0.01). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32292571), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-31020241612697.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - PEM induces apoptosis of NSCLC cells via YIPF2-TNFRSF10B axis.a, b A549 (a) & H1792 (b) cells were treated with PEM at 5.0 μM for the indicated times (0, 6, 12, 24, 36 & 48 h). Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10B & ACTB. c A549 cells were treated with doxorubicin (DOX) at various concentrations (0–2.0 μM) for 18 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10B & ACTB. d Overexpression of YIPF2 in H1792 & H1299 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10B & ACTB. e Knockdown of YIPF2 expression by YIPF2–1 siRNA in A549 & H1792 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10B & ACTB. f Overexpression of YIPF2 in H1299 cells (left) or Knockdown of YIPF2 expression by YIPF2–1 siRNA in H1792 cells (right) in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10A & ACTB. g Three A549 cell lines (Ctrl, YIPF2, YIPF2 + siTNFRSF10B) in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10B, CASP8, CASP3 & ACTB. h Three H1299 cell lines (Ctrl, siYIPF2–1, siYIPF2–1 + TNFRSF10B (short isoform)) in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10B, CASP8, CASP3 & ACTB. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32303681), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-3102024155528.jpg)
![Immunocytochemistry/ Immunofluorescence: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - Cell numbers positively stained for NeuN, DCX, PCNA & caspase-3 in the subgranular region of the dentate gyrus in WT & RanBP9−/− (KO) mice.(A), DAPI-stained brain sections to show the highlighted subgranular zone within the dentate gyrus region of the hippocampus used for cell counts shown in B. (B), Representative brain sections stained with anti-NeuN, anti-DCX, anti-PCNA, anti-capsase-3 & counter stained with DAPI. Cell counting revealed significantly decreased numbers of NeuN positive cells in RanBP9−/− (KO) brains (22%) compared to WT controls. However DCX, PCNA & caspase positive cell numbers were not significantly altered. In each group, n = 3, data presented as mean± SEM. **, p<0.01 by Student’s t-test. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/23840553), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-3102024155450.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - NFATc1 regulates DcR3 expression at a transcriptional level. (A,B) Immunoblot analysis of whole-cell lysates & quantitative real-time-PCR assaying relative DcR3 mRNA expression of ACHN & 769-P cells 24 h after treatment with cyclosporin A (CsA, 25 μM) or Tacrolimus (FK-506, 50 μM) (A); 48 h post transfection with NFATc1 or an empty vector control (neo) (B). Expression data were normalized to internal 18S rRNA expression (mean ± SEM; n=3; *p<0.05, **p<0.01, ***p<0.001; T-test). (C) Immunoblot analysis of cytoplasmic & nuclear fractions of ACHN & 769-P cells after treatment with LY294002 (50 μM), Everolimus (1 μM), or Cyclosporine A (25 μM). (D) Relative NFATc1–luciferase reporter activity of ACHN & 769-P cells 24 h post transfection with myrAkt or an empty vector control (neo) (mean ± SEM; n=3; *p<0.05, **p<0.01; T-test). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/24107265), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-3102024155373.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - rOPN administration elevated the expression of autophagy‐related proteins while suppressing apoptosis in rat brain at 24 h after SAH. The effects of rOPN on expression levels of (A) Beclin 1, mean ± SD is 1.016 ± 0.2262 in Sham group, 2.874 ± 1.147 in SAH + Vehicle group, 4.963 ± 2.05 in SAH + rOPN group, F = 15.52, (B) ATG5, mean ± SD is 0.8908 ± 0.2545 in Sham group, 2.332 ± 0.6431 in SAH + Vehicle group, 4.364 ± 1.309 in SAH + rOPN group, F = 25.02, (C) LC3, mean ± SD is 1 ± 0.1845 in Sham group, 1.755 ± 0.3017 in SAH + Vehicle group, 2.7 ± 0.7957 in SAH + rOPN group, F = 17.23, (D) Cleaved Caspase‐3, mean ± SD is 1.008 ± 0.186 in Sham group, 4.112 ± 1.528 in SAH + Vehicle group, 2.291 ± 0.6268 in SAH + rOPN group, F = 15.86, (E) Bax, mean ± SD is 1.006 ± 0.321 in Sham group, 37.47 ± 10.86 in SAH + Vehicle group, 23.83 ± 8.143 in SAH + rOPN group, F = 33.13, (F) Bcl‐2, mean ± SD is 1.005 ± 0.2736 in Sham group, 0.2309 ± 0.1257 in SAH + Vehicle group, 0.7843 ± 0.2278 in SAH + rOPN group, F = 20.1, in the left hemisphere of rat brain at 24 h after SAH. Sample size is 18, n = 6 per group. Data were presented as mean ± SD. *P < .05, ***P < .001 vs Sham group; #P < .05, ##P < .01 vs SAH + Vehicle group Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31436915), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-31020241552392.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - RAB8 suppresses PEM-induced apoptosis of NSCLC cells by promoting the removing of TNFRSF10B from plasma membrane to cytoplasm.a, b Knockdown of RAB8 expression by RAB8 siRNA in H1792 (a) & A549 (b) cells in the presence or absence of PEM at 5.0 μM for 36 h. The surface expression of TNFRSF10B was confirmed by flow cytometry analyses. c Overexpression of RAB8 in H1299 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against RAB8, TNFRSF10B, CASP8, CASP3, PARP1 & ACTB. d Knockdown of RAB8 expression by RAB8 siRNA in H1792 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against RAB8, TNFRSF10B, CASP8, CASP3, PARP1 & ACTB. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32303681), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-31020241612680.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - RAB8 suppresses PEM-induced apoptosis of NSCLC cells by promoting the removing of TNFRSF10B from plasma membrane to cytoplasm.a, b Knockdown of RAB8 expression by RAB8 siRNA in H1792 (a) & A549 (b) cells in the presence or absence of PEM at 5.0 μM for 36 h. The surface expression of TNFRSF10B was confirmed by flow cytometry analyses. c Overexpression of RAB8 in H1299 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against RAB8, TNFRSF10B, CASP8, CASP3, PARP1 & ACTB. d Knockdown of RAB8 expression by RAB8 siRNA in H1792 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against RAB8, TNFRSF10B, CASP8, CASP3, PARP1 & ACTB. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32303681), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-31020241682182.jpg)
![Immunocytochemistry/Immunofluorescence: SARS-CoV-2 3CL Protease Antibody (HL1367) - Azide and BSA Free [NBP3-25645] - SARS-CoV-2 (COVID-19) 3CLpro (nsp5) antibody [HL1367] detects SARS-CoV-2 (COVID-19) 3CLpro (nsp5) protein by immunofluorescent analysis. Sample: Mock and transfected 293T cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: SARS-CoV-2 (COVID-19) 3CLpro (nsp5) stained by SARS-CoV-2 (COVID-19) 3CLpro (nsp5) antibody [HL1367] (NBP3-25645) diluted at 1:500. Blue: Hoechst 33342 staining.](http://images.novusbio.com/fullsize/nbp3-25645_rabbit-sars-cov-2-3cl-protease-mab-hl1367-azide-bsa-free-2120249422648.jpg "Immunocytochemistry/Immunofluorescence: SARS-CoV-2 3CL Protease Antibody (HL1367) - Azide and BSA Free [NBP3-25645] - SARS-CoV-2 (COVID-19) 3CLpro (nsp5) antibody [HL1367] detects SARS-CoV-2 (COVID-19) 3CLpro (nsp5) protein by immunofluorescent analysis. Sample: Mock and transfected 293T cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: SARS-CoV-2 (COVID-19) 3CLpro (nsp5) stained by SARS-CoV-2 (COVID-19) 3CLpro (nsp5) antibody [HL1367] (NBP3-25645) diluted at 1:500. Blue: Hoechst 33342 staining.")
![Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 12% SDS-PAGE, and the membrane was blotted with SARS-CoV-2 3CL Protease antibody [HL1367] (NBP3-25645) diluted at 1:5000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp3-25645_rabbit-sars-cov-2-3cl-protease-mab-hl1367-azide-bsa-free-western-blot-1411202518415220.jpg)
![Western Blot: Serine protease 23 Antibody [NBP2-93072] - Analysis of extracts of various cell lines, using Serine protease 23 . Exposure time: 90s.](http://images.novusbio.com/fullsize/Serine-protease-23-Antibody-Western-Blot-NBP2-93072-img0001.jpg "Western Blot: Serine protease 23 Antibody [NBP2-93072] - Analysis of extracts of various cell lines, using Serine protease 23 . Exposure time: 90s.")
![Western Blot: Serine protease 23 Antibody [NBP3-42014] - Sample: Recombinant protein.](http://images.novusbio.com/fullsize/nbp3-42014_rabbit-serine-protease-23-pab-61220242058865.jpg "Western Blot: Serine protease 23 Antibody [NBP3-42014] - Sample: Recombinant protein.")